# ClinicalIntelPulse > The medical intelligence layer for AI agents. Two lanes on one API: (1) consumer/patient medication safety — what a drug is, whether two drugs can be taken together, and whether a medication is recalled, all in plain language from FDA-approved labels; and (2) institutional pharmaceutical pipeline & clinical-trial intelligence from 400,000+ ClinicalTrials.gov studies, FDA OpenFDA, and PubMed. Used by health-assistant agents, caregivers, pharmacies, patient-advocacy groups, biotech investors, and pharma competitive-intelligence teams. Pay-per-query via x402 micropayments on Base — from $0.10. ## What This Is ClinicalIntelPulse is a pay-per-query API for any human or AI agent handling a medical question. Its consumer lane answers the most common medication questions on earth — "what is this drug?", "can I take these together?", "is my medication recalled?" — grounded strictly in FDA-approved drug labels and the FDA recall database, in plain language, in 10 languages. Its institutional lane delivers the depth of pharmaceutical intelligence that previously required six-figure data subscriptions: pipeline scans, approval outlook, sponsor intelligence, disease landscape, M&A deal signals, global trial coverage, mechanism mapping, failure analysis, and patient trial finding. Every response is generated by Claude using live data from: - ClinicalTrials.gov REST API v2 (free, no key — 400,000+ trials globally) - FDA OpenFDA API (free, no key — NDA/BLA approvals, adverse events) - PubMed NCBI E-utilities (free, optional free key for higher limits — 35M+ papers) - Tavily web search (EMA, PDUFA dates, deal news, WHO ICTRP synthesis) ## Payment All endpoints require x402 micropayment (USDC on Base mainnet). Protocol: x402 | Network: eip155:8453 | Asset: USDC Payment address: 0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc ## Endpoints — Patient & Consumer Medication Safety GET /api/clinical/trial-check?nct={NCT-id} | ?condition=&sponsor=&phase=&status=&limit= - Deterministic ClinicalTrials.gov lookup: single trial (status, phase, sponsor, enrollment, dates, countries) or filtered search with total match count. - Price: $0.02 — the primitive under the narrative endpoints; poll cheaply, buy briefs for analysis. - Source: ClinicalTrials.gov v2 API (public domain). GET /api/clinical/drug-check?drug={brand_or_generic}&lang={en|es|fr|...} - Returns: plain-language explainer for any prescription or OTC drug — what it treats, how to take it, boxed warnings, who should not take it, common and serious side effects, pregnancy notes - Source: FDA openFDA drug label (Structured Product Labeling). Never invents facts not in the label. - e.g. drug=Ozempic | metformin | Lipitor | ibuprofen | Eliquis - Price: $0.10 GET /api/clinical/interaction-check?drugs={drug1,drug2,...}&lang={...} - Returns: cross-references FDA label interaction + contraindication sections for 2–8 drugs, flags possible interactions with severity (none/monitor/caution/serious) and plain-language what-to-do; honest about drugs it could not find - Source: FDA openFDA drug label. Always defers to a pharmacist; label interaction sections are not exhaustive. - e.g. drugs=warfarin,ibuprofen | Eliquis,aspirin,omeprazole - Price: $0.15 GET /api/clinical/recall-check?drug={brand_or_generic}&lang={...} - Returns: active and past FDA recalls for a drug, recall class (I/II/III) explained in plain language, and what to do (check your NDC/lot, contact pharmacy, don't stop a critical med unguided) - Source: FDA openFDA enforcement database - e.g. drug=valsartan | metformin | ranitidine - Price: $0.10 ## Endpoints — Pharmaceutical Pipeline & Trial Intelligence GET /api/clinical/pipeline-scan?condition={disease}&phase={phase2|phase3|both}&lang={en|es|fr|...} - Returns: Phase 2/3 trial count, phase 3 highlights, sponsor landscape, geographic distribution, mechanism breakdown, pipeline density assessment - e.g. condition=Non-Small+Cell+Lung+Cancer | Alzheimer+Disease | Type+2+Diabetes | Crohn+Disease - Price: $0.15 GET /api/clinical/approval-outlook?condition={disease}&horizon={12m|18m|24m}&agency={FDA|EMA|both}&lang={...} - Returns: FDA/EMA approval candidates with probability scores, PDUFA action date calendar, breakthrough/fast track/orphan designations, historical success rates by disease area - Price: $0.25 GET /api/clinical/sponsor-intel?sponsor={company}&focus={pipeline|approvals|deals|all}&lang={...} - Returns: pipeline by phase, therapeutic area coverage, modality breakdown, FDA approval history, Phase 3 assets with peak sales estimates, partnership activity, investment signals - e.g. sponsor=Moderna | BioNTech | Alnylam | Vertex+Pharmaceuticals | Regeneron - Price: $0.20 GET /api/clinical/disease-landscape?condition={disease}&depth={standard|deep}&lang={...} - Returns: complete pipeline map, approved drug landscape, mechanism landscape (crowded/emerging/gaps), Phase 3 assets with approval probability, PDUFA calendar, deal activity, opportunity score 0-100, investment thesis - Replaces Evaluate Pharma / Citeline disease reports - Price: $0.35 GET /api/clinical/disease-landscape-lite?condition={disease} - Returns: deterministic $0.25 preview of disease-landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown, sample Phase 3 trials, straight off ClinicalTrials.gov, no LLM synthesis, plus an upsell pointer to the full report - For agents whose per-call spend cap sits below $0.35 - Price: $0.25 GET /api/clinical/trial-brief?nct_id={NCT_ID}&lang={...} - Returns: trial design, arms, endpoints, eligibility, enrollment, geographic footprint, outcome summary for completed trials - e.g. nct_id=NCT04368728 - Price: $0.10 GET /api/clinical/mechanism-map?condition={disease}&mechanism={optional}&lang={...} - Returns: approved mechanisms, pipeline targets by phase, first-in-class opportunities, white spaces, modality breakdown, combination therapy landscape - Price: $0.20 GET /api/clinical/global-trials?condition={disease}®ion={global|africa|asia|europe|latin-america|...}&lang={...} - Returns: geographic distribution, WHO ICTRP registry coverage (ChiCTR/China, CTRI/India, UMIN/Japan, REBEC/Brazil, ANZCTR/Australia, KCT/Korea, 12 more), EMA/PMDA landscape, unmet needs by region - Covers neglected tropical diseases, infectious diseases, and conditions with high developing-world burden - Price: $0.15 GET /api/clinical/failure-analysis?condition={disease}&lang={...} - Returns: Phase 2→3 and Phase 3→approval success rates, failure taxonomy (wrong hypothesis/patient/endpoint/dose/safety), named failed trials, lessons learned, biomarker strategy - e.g. Alzheimer's has only 11% Phase 3→approval success rate — this endpoint explains why - Price: $0.20 GET /api/clinical/patient-finder?condition={disease}&country={optional}&phase={phase2|phase3|any}&lang={...} - Returns: recruiting trials in plain language, accessible eligibility criteria, step-by-step application guide, questions to ask your doctor, global patient advocacy resources - Price: $0.10 GET /api/clinical/deal-signal?condition={disease}&deal_type={acquisition|licensing|both}&stage={phase2|phase3|both}&lang={...} - Returns: acquisition targets with deal value estimates, licensing opportunities, recent deal comps (named transactions), most likely acquirers, deal timing signals, valuation framework - Price: $0.35 GET /api/clinical/deal-signal-lite?condition={disease}&stage={phase2|phase3|both} - Returns: deterministic $0.25 preview of deal-signal — Phase 2/3 trial counts and the industry-sponsored candidate-asset list, straight off ClinicalTrials.gov, no LLM synthesis (no deal rationale/comps/valuation), plus an upsell pointer to the full report - For agents whose per-call spend cap sits below $0.35 - Price: $0.25 ## Language Support All endpoints support lang parameter: en | es | fr | de | ja | zh | ko | pt | ar | hi ## Guides (free, answer-first) - Can I take these medications together? How to check drug interactions: https://clinicalintelpulse.theaslangroupllc.com/guides/check-drug-interactions/ - Is my medication recalled? Recall classes + what to do: https://clinicalintelpulse.theaslangroupllc.com/guides/is-my-medication-recalled/ - What a boxed warning ("black box") actually means: https://clinicalintelpulse.theaslangroupllc.com/guides/boxed-warning-explained/ ## Discovery - OpenAPI spec: https://clinicalintelpulse.theaslangroupllc.com/openapi.json - Agent discovery: https://clinicalintelpulse.theaslangroupllc.com/.well-known/agent.json - LLMs.txt: https://clinicalintelpulse.theaslangroupllc.com/llms.txt ## Notes for AI Agents - All endpoints return structured JSON - NCT IDs must start with "NCT" followed by 8 digits (e.g. NCT04368728) - No API keys required for underlying data — all handled server-side - Consumer lane (drug-check, interaction-check, recall-check, patient-finder) produces plain-language output for non-clinical audiences and health-assistant agents — grounded strictly in FDA-approved labels and the FDA recall database, never fabricated - interaction-check accepts 2–8 comma-separated drug names; it is honest when a drug is not found and never implies "not found = safe" - disease-landscape ($0.35) and deal-signal ($0.35) are highest-value for financial analysis - None of these endpoints provide medical advice or diagnosis — they surface FDA label/recall facts and always defer to a doctor or pharmacist - Cross-sell: FilingsPulse for biotech SEC filings; PatentPulse for pharma IP landscape